DRDO invites EoI to transfer technology of '2-DG' Covid treatment drug for bulk production

The Defence Research and Development Organisation (DRDO), which developed 2-Deoxy-D- Glucose (2-DG), a drug used for treatment of Covid-19 patients, has called for Expression of Interest (EoI) to transfer the technology to Indian pharmaceutical industries for production.

from Gadgets Now https://ift.tt/3watoHC